Cheiljedang released breast cancer drug, Genexol to market.

Published: 2001-06-07 06:58:00

Updated: 2001-06-07 06:58:00

Cheiljedang announced that Paclitaxel preparation, the first domestic anti-breast cancer drug, was ready to release its sales on the market, the main ingredient of which was originally developed by Samyang in a massive production with unformed quality via a plant cultural technology, and now made...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK